Drugs / FT
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00400023 Comparator | Sep 2006 → May 2007 | neoplasm | Taiho Oncology, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00400023 ↗ |
| Route | Oral | “FT will be administered as an 800 mg oral fixed dose” NCT00400023 ↗ |